Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma

Pediatric Blood and Cancer

Volumn 50, Issue 3, 2008, Pages 699-700

  Rook, James ^a   Rosser, Tena ^b   Fangusaro, Jason ^b   Finlay, Jonathan ^b  

^a LOMA LINDA UNIVERSITY CHILDREN S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Brain tumor; Encephalopathy; Neurotoxicity; Paclitaxel; Transient

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; GEMCITABINE; OXALIPLATIN; PACLITAXEL; TEMOZOLOMIDE; THIOTEPA; TOPOTECAN;

ACUTE TOXICITY; ADOLESCENT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAIN DISEASE; BRAIN RADIATION; BRAIN TUMOR; CANCER CHEMOTHERAPY; CASE REPORT; CHILDHOOD CANCER; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES INSIPIDUS; DISEASE COURSE; DRUG INFUSION; DRUG MEGADOSE; FEMALE; GERM CELL TUMOR; HUMAN; HYPOPITUITARISM; MULTIPLE CYCLE TREATMENT; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT CANCER; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN DISEASES; CARBOPLATIN; CEREBRAL VENTRICLE NEOPLASMS; COMBINED MODALITY THERAPY; CONSCIOUSNESS DISORDERS; CRANIAL IRRADIATION; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEOXYCYTIDINE; ETOPOSIDE; FEMALE; GERMINOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPOPHYSECTOMY; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; PITUITARY NEOPLASMS; THIOTEPA; TOPOTECAN;

EID: 38549181565     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21040     Document Type: Article

References (15)

1. Wani MC, Taylor HL, Wall ME, et al. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 1971;93:2325-2327.
2. Rowinsky EK, Cazenave LA, Donehower RC. Taxol: A novel investigational antimicrotubule agent. J Natl Cancer Inst 1990;82:1247-1259.
3. Markman M. Managing taxane toxicities. Support Care Cancer 2003;11:144-147.
4. Glantz MJ, Choy H, Kearns CM, et al. Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. J Natl Cancer Inst 1995;87:1077-1081.
5. Rowinsky EK, Donehower RC. The clinical pharmacology of paclitaxel (Taxol). Semin Oncol 1993;20:16-25.
6. Ziske CG, Schottker B, Gorschluter M, et al. Acute transient encephalopathy after paclitaxel infusion: report of three cases. Ann Oncol 2002;13:629-631.
7. Perry JR, Warner E. Transient encephalopathy after paclitaxel (Taxol) infusion. Neurology 1996;46:1596-1599.
8. Nieto Y, Cagnoni PJ, Bearman SI, et al. Acute encephalopathy: A new toxicity associated with high-dose paclitaxel. Clin Can Res 1999;5:501-506.
9. Lachkar S, Bota S, Nouvet G. Acute encephalopathy after infusion of paclitaxel. Rev Mal Respir 2006;23:73-77.
10. Webster LK, Crinis NA, Morton CG, et al. Plasma alcohol concentrations in patients following paclitaxel infusion. Cancer Chemother Pharmacol 1996;37:499-501.
11. Habazettl H, Vollmar B, Rohrich F, et al. Anesthesiologic efficacy of propanidid as a liposome dispersion. An experimental study with rats. Anaesthesist 1992;41:448-456.
12. Toung TJ, Bunke FJ, Grayson RF, et al. Effects of cyclosporine on cerebral blood flow and metabolism in dogs. Transplantation 1992;53:1082-1088.
13. Collins P, Wilkie M, Razak K, et al. Cyclosporin and cremaphor modulate von Willebrand factor release from cultured human endothelial cells. Transplantation 1993;56:1218-1223.
14. Lodge NJ. Direct vasoconstrictor effects of sandimmune (cyclosporin A) are mediated by its vehicle cremophor EL: Inhibition by the thromboxane A2/prostaglandin endoperoxide receptor antagonist ifetroban. J Pharmacol Exp Ther 1994;271:730-734.
15. Webster LK, Crinis NA, Morton CG, et al. Plasma alcohol concentrations in patients following paclitaxel infusions. Cancer Chemother Pharmacol 1996;37:499-501.